S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 83.1 TWD Market Closed
Market Cap: 9.9B TWD

Intrinsic Value

The intrinsic value of one SCI Pharmtech Inc stock under the Base Case scenario is 70.42 TWD. Compared to the current market price of 83.1 TWD, SCI Pharmtech Inc is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
70.42 TWD
Overvaluation 15%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
SCI Pharmtech Inc

SCI Pharmtech Inc
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for SCI Pharmtech Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

SCI Pharmtech Inc
TWSE:4119
TW
Pharmaceuticals
Market Cap
9.9B TWD
IPO
Aug 12, 2002
TW
Pharmaceuticals
Market Cap
9.9B TWD
IPO
Aug 12, 2002
Price
NT$false
EPS
NT$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SCI Pharmtech Inc?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about SCI Pharmtech Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
SCI Pharmtech Inc

Current Assets 2.1B
Cash & Short-Term Investments 543.5m
Receivables 869.5m
Other Current Assets 723.3m
Non-Current Assets 5.1B
Long-Term Investments 473.2m
PP&E 4.3B
Intangibles 39.8m
Other Non-Current Assets 302.6m
Efficiency

Free Cash Flow Analysis
SCI Pharmtech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
SCI Pharmtech Inc

Revenue
1.4B TWD
Cost of Revenue
-1B TWD
Gross Profit
383.2m TWD
Operating Expenses
-223.3m TWD
Operating Income
159.9m TWD
Other Expenses
324.3m TWD
Net Income
484.2m TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

SCI Pharmtech Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Net Income
ROE is Increasing
Exceptional 1-Year Revenue Growth
47/100
Profitability
Score

SCI Pharmtech Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

SCI Pharmtech Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
85/100
Solvency
Score

SCI Pharmtech Inc's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
SCI Pharmtech Inc

There are no price targets for SCI Pharmtech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SCI Pharmtech Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one SCI Pharmtech Inc stock?

The intrinsic value of one SCI Pharmtech Inc stock under the Base Case scenario is 70.42 TWD.

Is SCI Pharmtech Inc stock undervalued or overvalued?

Compared to the current market price of 83.1 TWD, SCI Pharmtech Inc is Overvalued by 15%.

Back to Top